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Abstract Tetratricopeptide- and sel1-like repeat (SLR)
proteins modulate various cellular activities, ranging from
transcription regulation to cell-fate control. Helicobacter
cysteine-rich proteins (Hcp) consist of several SLRs that
are cross-linked by disulfide bridges and have been
implicated in host/pathogen interactions. Using pull-down
proteomics, several human proteins including Nek9,
Hsp90, and Hsc71 have been identified as putative human
interaction partners for HcpC. The interaction between the
NimA-like protein kinase Nek9 and HcpC has been vali-
dated by ELISA and surface plasmon resonance. Recom-
binant Nek9 is recognized by HcpC with a dissociation
constant in the lower micromolar range. This interaction is
formed either directly between Nek9 and HcpC or via the
formation of a complex with Hsc71. The HcpC homologue
HcpA possesses no affinity for Nek9, suggesting that the
reported interaction is rather specific for HcpC. These
results are consistent with previous observations where
Nek9 was targeted upon bacterial or viral invasion. How-
ever, further experiments will be required to show that the
reported interactions also occur in vivo.
Abbreviations
Mbp Maltose binding protein
TFA Trifluoracetic acid
DTT Dithiothreitol
BSA Bovine serum albumine
TCEP Tris(2-carboxyethyl)phosphine
Introduction
Molecular activity, thermodynamic stability, and structural
integrity of proteins are often modulated by the binding of
specialized protein–protein interaction modules, such as
tetratricopeptide repeat (TPR) or other repeat proteins.
Sel1-like repeat proteins (SLR) have initially been identi-
fied in the genome sequences of eukaryotes and bacteria
and it has been hypothesized that some of them might have
been acquired by horizontal gene transfer [41]. SLRs are
characterized by a short sequence motif consisting of
36–44 amino acids that fold into pairs of anti-parallel
alpha-helices. Full-length SLR proteins comprising 3 to
more than 20 repeating units form right-handed super-
helical molecules. SLR proteins possess structural simi-
larity with TPR proteins but because of different consensus
sequence lengths TPR and SLR proteins differ in their
super-helical parameters [25].
The SLR has been named after the C. elegans sel-1 gene
product (sel: suppressor-enhancer of lin), a molecule that
participates in cell-fate control by modulating lin-12
activity [14]. The human homologue Sel1L resides in the
endoplasmic reticulum (ER) and translocates misfolded
proteins across the ER membrane for degradation in the
cytoplasm [5, 20, 32]. Besides the membrane-anchored
Sel1L, alternative splicing generates soluble Sel1 isoforms
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that have been localized in secretory compartments and in
cell/cell contact areas [3]. Differential expression of Sel1L
has been associated with increased risks for breast, pan-
creatic and esophageal cancers [4, 13].
SLR proteins have also been identified in several pro-
karyotes by genome sequencing experiments but the
molecular functions of the vast majority of bacterial SLR
proteins are unknown. Functional annotations exist for
several SLR proteins from bacteria that live in tight asso-
ciation with eukaryotes, such as Helicobacter pylori,
Legionella pneumophila, Pseudomonas aeruginosa, or
Sinorhizobium meliloti (reviewed in [31]). The SLR pro-
teins LpnE, EnhC, and LidL from L. pneumophila enhance
the entry of bacteria into host cells [6, 24, 34]. LpnE rec-
ognizes several eukaryotic proteins such as obscurin-like
protein 1 or the N-terminal domain of the inositol poly-
phosphate 5-phosphatase OCRL1 [35, 55].
Here, we investigate the molecular function of Heli-
cobacter cystein-rich protein (Hcp) C a SLR protein from
the human pathogen H. pylori. HcpC belongs to a family
of conserved hypothetical proteins, which are character-
ized by pairs of cysteine residues that cross-link adjacent
SLR repeats [29]. All genomes of H. pylori strains that
have been sequenced so far contain 8 to 9 hcp genes.
The analysis of several hcp genes in a large collection of
H. pylori strains revealed signatures of positive selection
suggesting that some hcp gene products are important for
the adaptation of H. pylori in different human popula-
tions [38]. This assumption is corroborated by the
observation that some hcp genes undergo phase variation
to allow H. pylori to evade the immune system response
[47].
Although most Hcp homologues have been analyzed at
the gene level, the detection of high antibody titers against
HcpA, -C, and -E confirmed that these molecules are
expressed under in vivo conditions and recognized by the
human immune system [30]. Serological analysis of
H. pylori positive patients with different clinical manifes-
tations established HcpC as a virulence factor for chronic
atrophic gastritis and gastric cancer sometimes with similar
significance scores such as the classical H. pylori virulence
factors CagA and VacA [12, 15].
Very little is known about the biological functions of
Hcp molecules. In cellular assays using murine spleno-
cytes, recombinant HcpA triggered the release of large
amounts of the pro-inflammatory cytokines IFN-c and
interleukin-6 [8]. Furthermore, small amounts of HcpA
caused morphological changes and enhanced cellular
adherence, phagocytosis and CD11b expression in assays
using the human myeloid Thp1 cell line [9]. These obser-
vations were interpreted as a HcpA-dependent maturation
of Thp1 cells from a motile monocytic toward a sessile
macrophage-like phenotype.
HcpC did not exert any of these effects. However, the
crystal structure of HcpC [26] in conjunction with the
cellular functions of HcpA and the results of the serological
studies mentioned above gave rise to the hypothesis that
HcpC might indeed recognize proteins from the human
host. To test this hypothesis, we performed pull-down
experiments and validated one putative interaction partner
by ELISA and surface plasmon resonance experiments.
Methods
Pull-Down Analysis with Mbp-HcpC
HcpC (hp1098) and HcpA (hp0211) were expressed
recombinantly in E. coli and purified as described previously
[9]. For pull-down experiments, semi-pure Mbp-HcpC with
a C-terminal His6-tag was used. Protein concentrations were
determined by UV-spectroscopy using the absorption coef-
ficients e280 (Mbp-HcpC) = 1.28 ml cm
-1 mg-1, e280
(Mbp-HcpA) = 1.27 ml cm-1 mg-1, e280 (HcpC) = 0.92
ml cm-1 mg-1 and e280 (HcpA) = 0.83 ml cm
-1 mg-1.
Pull-down experiments were performed as follows.
Thp1 cells were grown up to a density of 106 cells/ml,
harvested by centrifugation (2009g, 5 min, 4C) and
washed with ice-cold PBS. Cells were re-suspended in
Thp1 lysis buffer (0.2 M sodium chloride, 20 mM Tris–
HCl, pH 7.4, 10% glycerol, 0.5% NP-40, 1 tablet Complete
protease inhibitor cocktail (Roche) per 50 ml buffer) and
kept on ice for 30 min. The lysate was cleared by centri-
fugation (20,0009g, 45 min, 4C) and filtration (0.45 lm
filter). Concentration of total protein was adjusted to
10 mg/ml. 60 ll of amylose affinity resin (New England
Biolabs) was washed three times with buffer B (0.2 M
sodium chloride, 20 mM Tris, pH 7.4) and split into three
aliquots. One aliquot was loaded with Mbp and two ali-
quots were loaded with Mbp-HcpC. The loaded resin was
washed three times with 1 ml buffer B. The Mbp and one
Mbp-HcpC loaded aliquots were incubated with a mixture
of 500 ll buffer B and 500 ll Thp1 cell extract at 4C over
night with constant agitation. As a negative control, the
second Mbp-HcpC loaded aliquot was incubated with 1 ml
buffer B. The resin was washed three times with buffer B
and the bound proteins were eluted with 30 ll of 10 mM
maltose in buffer B.
After adding 10 ll SDS-PAGE sample buffer, the
samples were analyzed on 12% pre-casted SDS-PAGE gels
(BioRad). Gels were stained with colloidal Coomassie Blue
(Roth) and each lane was cut into eight gel pieces and
transferred into a 96-well plate. Sample preparation was
performed with an automated Tecan pippetting station with
the following protocol. Samples were distained with 50%
acetonitrile (ACN) and reduced with 2 mM TCEP in
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25 mM ammonium bicarbonate (ABC) buffer, pH 8.2 for
1 h at 60C. Free thiol groups were acetylated with 25 mM
iodoacetamide in 25 mM ABC buffer for 1 h at darkness.
After withdrawal of the supernatant, the gel pieces were
washed twice with 50% ACN and digested with 50 ng
trypsin per gel piece in ABC buffer at 37C for 14 h. To
terminate the tryptic digestion and to elute peptides, the gel
pieces were washed two times with 5% TFA and 50%
ACN. After drying the samples in a speed-vac, the peptides
were dissolved in 2 M urea, 3% ACN, and 0.1% TFA and
desalted using C18 ZipTip
 (Millipore) following the
instructions of the manufacturer. Re-dissolved samples
were injected into an Eksigent-nano-HPLC system (Eksi-
gent Technologies, Dublin, USA) and separated on a self-
made reverse-phase tip column (0.075 mm 9 80 mm)
packed with C18 resin (AQ, 3 lm, 200A˚, Bischoff GmbH,
Leonberg, Germany). The column was equilibrated with
97% solvent A (1% ACN; 0.2% formic acid in water) and
4% solvent B (80% ACN, 0.2% formic acid in water).
Peptides were eluted using the following gradient:
0–5 min, 3–15% B; 5–55 min, 15–50% B; 55–60 min,
50–97% B at a flow rate of 0.2 ll/min. High accuracy mass
spectra were acquired at an LTQ-Orbitrap (Thermo Sci-
entific, Bremen, Germany) in the mass range of
300–2,000 m/z and a target value of 5 9 105 ions. Up to
four data dependent MS/MS were recorded in parallel at
the linear ion trap of the most intense ions with charge state
2? or 3? using collision-induced dissociation. Target ions
already selected for MS/MS were dynamically excluded
for 60 s. General mass-spectrometric conditions were:
normalized collision energy, 35%; ion selection threshold,
500 counts; activation, 0.25; and activation time, 30 ms for
MS/MS acquisitions. Peak lists were generated using
Mascot Distiller software 2.1.1 (Matrix Science Ltd.,
London, UK) and searched against the protein database
from UniProt_20100127 (www.uniprot.org) using the
Mascot search algorithm (Mascot 2.3). Peptide and protein
assignments were filtered for peptide probabilities greater
than 95% and protein probabilities greater than 99%.
Identified proteins must contain at least two peptides. The
list was manually curated for false-positive hits (e.g. gly-
cogen phosphorylase). These false-positive hits were not
automatically recognized in the control experiments,
because peptides were assigned to a different database
entry.
Expression and Purification of Nek9
Expression of Nek9 in Hek293 cells was described previ-
ously [45]. Briefly, the expression plasmid pCMV5flag-
Nek9 was a kind gift from Prof. Joe Avruch (Harvard
Medical School, Boston). Four 15 cm culture dishes were
inoculated with 1 ml Hek293 cells each. Cells were grown
in 25 ml DMEM-GlutaMAX
TM
medium (Gibco) supple-
mented with 10% fetal calf serum and 1% PenStrep (100
U/ml final concentration, Gibco) at 37C and 5% carbon
dioxide. When cells reached 50% confluence they were
transfected with 0.4 lg pCMV5flag-Nek9 vector per mil-
liliter medium using the polyethylenimine (linear poly-
ethylenimine, Mw 25000, Polyscience Inc.) transfection
method [10]. After 24 h the medium was withdrawn, cells
were washed with ice-cold PBS and detached with 10 mM
EDTA in ice-cold PBS. Cells were harvested by centrifu-
gation (2009g, 4 min, 4C) and lysed in 10 ml Hek lysis
buffer (0.15 M sodium chloride, 50 mM Tris–HCl, pH 7.1,
1 mM DTT, 1 mM EDTA, 0.6 mM EGTA, 1% (v/v) Tri-
ton X-100, 1 mM sodium vanadate, 1 tablet Complete-
EDTA free protease inhibitor cocktail (Roche) per 50 ml
lysis buffer) for 20 min under constant agitation at 4C.
The lysate was cleared by centrifugation (5,0009g,
20 min, 4C). The extract was either directly used for
crude-cell extract ELISA or loaded onto a 0.4 ml anti-flag
antibody affinity column (Sigma), which was equilibrated
with TBS (140 mM sodium chloride, 10 mM Tris–HCl,
pH 7.4). The column was washed with 10 column vol-
umes (CV) TBS until no protein eluted from the column.
Purified Nek9 was eluted by 5 CV 3flag peptide (Sigma)
in TBS at a concentration of 0.1 mg/ml. Protein con-
taining fractions were pooled and the buffer was replaced
against TBS supplemented with 10% (v/v) glycerol by
ultrafiltration. Aliquots of Nek9 at a concentration of
0.2 mg/ml were stored at -80C. Protein concentration
was determined by UV-spectroscopy (e280 (Nek9) =
0.99 ml cm-1 mg-1) using the flow-through of the con-
centration step as a blank. Protein purity was investigated
using silver stained 12% Laemmli gels or western-blot
analysis. Gels were blotted onto nitrocellulose membranes
and analyzed using a primary anti-flag mouse antibody
(Sigma, 1:2000 dilution) and an anti-mouse IgG second-
ary antibody conjugated to horseradish peroxidase
(Sigma, 1:4000 dilution). Blots were stained using a
luminescence kit (GE Healthcare) according to the
guidelines of the manufacturer.
Binding Analysis by ELISA
All ELISA experiments were performed in Nunc Maxisorb
96-well plates. All volumes were 50 ll/well if not stated
differently. After every step, the plate was washed three
times with water and three times with TBST (0.14 M
sodium chloride, 10 mM Tris–HCl, 0.2% (v/v) Tween-20,
pH 7.4). All binding steps were performed in B-TBST
(0.5% (w/v) BSA in TBST). For dose–response curves,
HcpA and HcpC were diluted in TBS to final concentra-
tions of 0.01 lg/ll and each well was coated for 90 min at
room temperature under constant agitation. To avoid
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unspecific binding, wells were blocked with 200 ll 2% (w/
v) BSA in TBST at 4C over night.
Serial dilutions of Hek293 cell extracts expressing flag-
tagged Nek9 in B-TBST were added and the plate was
incubated for 1 h at 4C. Initial protein concentration of
cell extract was measured by Bradford analysis (BioRad)
using BSA as a standard. Bound Nek9 was detected by an
anti-flag mouse antibody (Sigma, 1:3000 dilution) and the
bound primary antibody was detected by an anti-mouse
IgG antibody conjugate to horseradish peroxidase (Sigma,
1:5000 dilution) unless stated differently. Both antibodies
were incubated for 1 h at room temperature. Finally,
100 ll 3,3’,5,5’-tetramethylbenzidine reagent (Sigma) was
added for 3 to 4 min. The reaction was stopped with 2 M
sulfuric acid and the absorption was measured at 450 nm in
an ELISA-plate reader (Tecan).
For competition ELISA experiments, 10 nM Nek9 was
pre-incubated with HcpC at different concentrations for 1 h
at room temperature. Binding of Nek9/HcpC mixtures to
immobilized HcpC (0.15 lg/well) was reduced to 10 min
at room temperature and the amount of bound Nek9 was
determined as described before. Data were analyzed using
program SigmaPlot Version 11 (Systat Software). To
obtain the dissociation constant from the crude-cell extract
competition ELISA, the inverse of the fractional saturation
(1/v) was plotted over the inverse of the total HcpC con-
centration (1/a0) as described in [11]. Competition ELISA
data using purified proteins were analyzed by Scatchard
analysis and by nonlinear curve fitting. Data were fitted to
the single hyperbolic function v = (vmax 9 a0)/(Kd ? a0).
For Scatchard analysis, v/a was plotted over the fractional
saturation of Nek9 (v), which corresponds to (A0 - A)/A0.
A refers to the background subtracted absorptions at
450 nm at a given HcpC concentration. A0 refers to the
absorption in the absence of HcpC. The concentration of
free HcpC (a) corresponds to a0 - i0 9 v with a0 being
the total concentration of HcpC and i0 the total concen-
tration of Nek9 [11].
Surface Plasmon Resonance
SPR interaction analyses were performed using a Biacore
T100 optical biosensor (Biacore Life Sciences/GE Health-
care, Uppsala, Sweden). Series S Sensor Chips CM5,
N-hydroxysuccinimide (NHS), N-ethyl-N0-(3-dimethylami-
nopropyl)carbodiimide (EDC), and ethanolamine-HCl, as
well as sampling vials, and caps, were obtained from Bia-
core. Data were collected with the biosensor instrument at
20C. A solution of 10 mM HEPES, 0.15 M NaCl, 3 mM
EDTA, and 0.05% (v/v) surfactant P20, pH 7.4 was used as
running buffer.
To prepare the sensor chip for interaction analysis, a
series of solutions were injected over the chip surface. A
new CM5 sensor chip was inserted into the instrument and
the instrument primed with running buffer. The condi-
tioning solutions (100 mM HCl, 50 mM NaOH, 0.5% (w/
v) SDS, and water) were used to hydrate and clean the
dextran layer. Two aliquots of each conditioning solution
were injected over all four flow cells (Fc) for 60 s at a flow
rate of 100 ll/min.
A solution of 10 mM sodium acetate, pH 5.0 was used
as immobilization buffer. To minimize denaturation, Nek9
was diluted into the immobilization buffer only immedi-
ately before use to a final concentration of 40 lg/ml. Using
a flow rate of 10 ll/min, the surface of Fc2 was activated
for 7 min using a 1:1 mixture of 0.1 M NHS and 0.4 M
EDC, and 40 lg/ml Nek9 in immobilization buffer was
injected until 2500 RU were immobilized. This was fol-
lowed by the injection of a 0.1 mg/ml solution of BSA in
10 mM sodium acetate, pH 5.0 until a final total surface
density of 6,000 RU was reached. Residual-activated
groups on the surface were blocked by a 7 min injection of
1 M ethanolamine-HCl, pH 8.5. The reference flow cell
was coated as described for the flow cell with 6,000 RU
BSA only. An initial series of buffer blanks was injected
first to fully equilibrate the system. The analyte (HcpC)
samples were analyzed first from the lowest to the highest
concentration and then run in duplicate from the highest to
the lowest concentration. During each binding cycle, the
analyte was injected for 4 min at a flow rate of 50 ll/min
and dissociation was monitored for 900 s. The storage
buffer of the HcpC stock solution was replaced by the
running buffer by ultrafiltration. To completely remove
remaining amounts of HcpC bound to the sensor chip
surface, regenerations were performed by single 30 s
injections of 10 mM Na2CO3, 0.3 M KCl, pH 10 at a flow
rate of 30 ll/min.
Data collected on an SPR biosensor require processing
to remove systematic artifacts coming from nonspecific
binding, signal drift, and bulk refractive index changes.
Data sets were processed and analyzed using Biacore T100
Evaluation Software. Double referenced data for HcpC
were globally fitted to a simple 1:1 interaction steady-state
affinity model [33].
Results
Identification of HcpC Interaction Partners by Pull-
Down Proteomics
To identify putative interaction partners, we expressed
HcpC with a N-terminal Mbp- and a C-terminal His6-tag
[9]. After the first purification step, the semi-pure Mbp-
HcpC fusion protein was bound to amylose beads and the
immobilized fusion protein was incubated with Thp1 cell
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extract. Putative HcpC interaction partners co-eluted under
mild conditions using 10 mM maltose and were identified
using established procedures. To reject proteins that either
recognized the Mbp-tag or that were unspecific absorbed to
the amylose matrix control experiments with immobilized
Mbp were performed. Control experiments with immobi-
lized Mbp-HcpC in the absence of cell extract allowed the
rejection of contaminations from the Mbp-HcpC
purification.
Proteins that co-eluted with Mbp-HcpC but where
absent from the negative control experiments are summa-
rized in Table 1. One of the most significant putative
interaction partners is the NimA-like protein kinase Nek9,
which is involved in the control of spindle dynamics and
chromosome separation [45]. Nek9 is a cytoplasmic protein
that comprises a N-terminal protein kinase domain and a
central domain that contains seven regulator of chromo-
some condensation 1 (RCC1) repeats. The six identified
peptides were equally distributed over the entire sequence,
indicating that full-length Nek9 was identified. The
remaining hits can be clustered into three groups:
(i) molecular chaperones, (ii) nucleic acid binding proteins,
and (iii) miscellaneous hits.
(i) Several heat shock proteins (Hsp) co-eluted with
Mbp-HcpC. Besides the heat shock cognate (Hsc) 71 pro-
tein, we identified the beta-isoform of Hsp90. Hsp90 is
Table 1 Proteins that were identified from Thp1 cell extracts by pull-down with Mbp-HcpC
Protein Uniprot ID Unique
peptides
Peptides identified Sequence
coverage (%)
Mascot protein score
Heat shock protein HSP 90-beta Q9NTK6 7 ADLINNLGTIAK 14 267
GVVDSEDLPLNISR
HLEINPDHPIVETLR
NPDDITQEEYGEFYK
TLTLVDTGIGMTK
VILHLKEDQTEYLEER
YHTSQSGDEMTSLSEYVSR
Serine/threonine-protein kinase Nek9 Q8TD19 6 GAFGEATLYR 9 197
KLEGGQQVGMHSK
LGINLLGGPLGGK
LGLDSEEDYYTPQKVDVPK
STPQKLDVIK
VASEAPLEHKPQVEASSPR
Tubulin alpha-ubiquitous chain P68363 4 AVFVDLEPTVIDEVR 16 183
QLFHPEQLITGKEDAANNYAR
TIGGGDDSFNTFFSETGAGK
VGINYQPPTVVPGGDLAK
Heat shock cognate 71 kDa protein P11142 4 LSKEDIER 6 180
NSLESYAFNMK
TTPSYVAFTDTER
VQVEYKGETK
Malectin Q14165 2 KFAEVYFAQSQQKV 8 155
RSNPEDQILYQTERY
Heterogeneous nuclear ribonucleoprotein U Q00839 2 NFILDQTNVSAAAQR 3 116
QMADTGKLNTLLQR
Transcription factor ETV6 P41212 5 ALLLLTKEDFR 9 113
LSEDGLHR
SPLDNMIR
TNMTYEK
TPDEIMSGR
Nucleolin P19338 4 ATFIKVPQNQNGK 8 92
GFGFVDFNSEEDAK
GLSEDTTEETLKESFDGSVR
IVTDRETGSSK
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regarded as a ubiquitous cytoplasmic protein that partici-
pates in protein folding, transportation, degradation, and
cell signalling events (reviewed in [40]). Hsc71 is a con-
stitutively expressed molecular chaperone located in the
cytoplasm and at the cell surface [49], which also partici-
pates in membrane trafficking (reviewed in [22]) and
antigen maturation [21].
(ii) Three proteins were identified that recognize nucleic
acids. Nucleolin and transcription factor ETV6 are both
localized in the nucleus and the cytoplasm. In the nucleus,
nucleolin recognizes pre-mRNA splice sites and telomeric
DNA sequences [17]. However, nucleolin was also local-
ized at the plasma membrane surface [50]. The heteroge-
neous nuclear ribonucleoprotein U (hnRNP U) also
recognizes single- and double-stranded DNA and mRNA.
It is regarded as a nuclear and cytoplasmic protein, where it
participates in the spliceosome C complex. However,
together with nucleolin it has previously been localized at
the plasma membrane [19]. The transcription factor ETV6
can inhibit Ras-dependent growth and comprises two
domains, a N-terminal SAM-like protein recognition
domain and a C-terminal ETS-like DNA-binding domain
[57].
(iii) The last cluster contains the ubiquitous tubulin-
alpha chain. Tubulin-alpha and tubulin-beta form dimers
that build up the microtubule protofilament. Tubulin-beta
was also recognized in the Mbp-HcpC pull-down experi-
ments. Since it was present in the negative control tubulin-
beta is not listed in Table 1. Malectin is anchored in the ER
membrane where it might be involved in the processing
and secretion of N-glycosylated proteins [48].
Validation of the Interaction Between Nek9 and HcpC
by Crude-Cell Extract ELISA
Since the validation of all eight putative HcpC interaction
partners was beyond the scope of this study, we selected
one possible hit for further in vitro analysis. We unselected
Hsp90 and tubulin because these hits are highly expressed
in Thp1 cells. We rather concentrated on Nek9, because
this hit was clearly identified in the pull-down experiment
albeit its weak expression in Thp1 cells and further evi-
dence came from a sequence database search. According to
the Rosetta stone model, certain domains are predicted to
interact because their homologues are fused in a so called
Rosetta stone protein [27]. Thus, a Rosetta stone protein
that would support an interaction between Nek9 and HcpC
would contain a SLR domain fused to either a protein
kinase domain or a RCC1 domain. Domain architectures
with N-terminal protein kinase and C-terminal SLR
domains are for example predicted for the Thermobifida
fusca Tfu_1658 gene product (Uniprot ID: Q47PC6), the
Naegleria gruberi 67437 gene product (Uniprot ID:
D2VEY2), or human eukaroytic elongation factor 2 kinase
(Uniprot ID: O00418).
To validate this interaction, flag-tagged Nek9 was
expressed in Hek293 cells as described previously [45].
HcpC and its close homologue HcpA were immobilized in
96-well plates and incubated with different amounts of
Nek9-expressing Hek293 cell extracts. The amounts of
bound Nek9 were quantified using an anti-flag antibody.
The dose–response curve reveals a clear interaction
between soluble Nek9 and immobilized HcpC, whereas no
such interaction was detected between Nek9 and HcpA
despite the high level of sequence identity among Hcps
(Fig. 1a). At protein concentrations above 100 lg/ml, the
amount of HcpC-bound Nek9 decreases, which can be
explained by a reduction of the affinity of Nek9 for HcpC
because of the high concentration of Triton X-100 in cell
extracts. Similar results have been obtained with the unc-
leaved Mbp-HcpC and Mbp-HcpA fusion proteins con-
firming that the N-terminal Mbp-tag does not prevent the
interaction between Nek9 and HcpC (data not shown).
To eliminate the possibility that Nek9 recognizes epi-
tops that become exposed upon immobilization of HcpC
and to obtain a quantitative estimate for the Nek9/HcpC
binding affinity the interaction was investigated using a
competition ELISA set-up. Here, the concentration of free
Nek9 in mixtures between crude-cell extracts and HcpC at
different concentrations was measured by ELISA. To
confirm that the interaction between Nek9 and immobilized
HcpC does not shift the equilibrium between Nek9 and
soluble HcpC, the Nek9/HcpC mixtures were analyzed by
two subsequent ELISA experiments. Since the signal of the
first measurement deviates less than 12% from the second
measurement the data were investigated by Scatchard
analysis and revealed a dissociation constant (Kd) of
(3.4 ± 0.2) lM (Fig. 1b, c).
Nek9 Recognizes HcpC with High Affinity
To investigate the possibility that the interaction between
Nek9 and HcpC is mediated by an endogenous protein,
Nek9 was purified from Hek293 cells by affinity chroma-
tography and the interaction was investigated by competi-
tion ELISA and surface plasmon resonance analysis. Nek9
was purified at a yield of 21 lg from a 100 ml Hek293 cell
culture. SDS-PAGE analysis revealed one major band that
represents Nek9, because it occurs at the expected molec-
ular weight and it is recognized by an anti-flag antibody.
However, the analysis also revealed a contamination with a
molecular weight of approximately 70 kDa that was shown
to be Hsc71 by in-gel proteolytic digestion and mass-
spectrometric analysis of peptides (Fig. 2a).
In a first approach, HcpC was immobilized in 96-well
plates and the interaction between immobilized HcpC and
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semi-pure Nek9 was inhibited by varying the concentra-
tions of soluble HcpC at a constant concentration of Nek9.
The dissociation constant between HcpC and purified Nek9
was determined by directly fitting the fractional saturation
as a function of total HcpC added (Fig. 2b). This analysis
revealed a dissociation constant of (0.5 ± 0.2) lM. The
Scatchard plot shows a straight line that intersects the
x-axis at 0.9, suggesting a 1:1 stoichiometry between Nek9
and HcpC. Since the concentration of semi-pure Nek9
(10 nM) is much smaller than the dissociation constant,
this analysis provides only a rough estimate [56].
In a second approach, the binding of soluble HcpC to
Nek9 was investigated by surface plasmon resonance
(SPR) analysis. In contrast to the ELISA experiments
where soluble Nek9 interacted with immobilized HcpC the
set-up was inverted. In the SPR set-up, Nek9 was immo-
bilized on the chip surface and the interaction with soluble
HcpC at concentrations between 90 and 7,290 nM was
monitored. Since association and dissociation rates were
extremely fast, reliable kon and koff values could not be
determined. Instead Kd was calculated based on steady-
state kinetics (Fig. 2c). The equilibrium dissociation con-
stant as determined from steady-state affinity fitting was
28 lM. SPR analysis also confirmed that immobilized
Nek9 is not recognized by soluble HcpA (inset in Fig. 2c).
Discussion
The implication of eukaryotic SLR proteins in cell-fate
control and the reported interactions between bacterial
SLR proteins and host cells [6, 9, 24, 34] prompted us
to identify human proteins that could interact with HcpC
from H. pylori. Using HcpC that was immobilized by
its N-terminal Mbp-tag and extracts from human Thp1
cells, we identified eight putative interaction partners
with reasonable significance.
Interestingly, several putative interaction partners are
localized in the cytoplasm or the nucleus. Only malectin,
Hsc71, hnRNP U, and nucleolin were reported to be
expressed either in the ER-lumen or at the cellular surface.
Although nucleolin is considered to be a nuclear or cyto-
plasmic protein it serves as a receptor for bacterial adher-
ence. Nucleolin that was localized at the plasma membrane
recognized the bacterial adherins intimin-alpha, -beta and -
gamma with high affinity [50, 51]. Therefore, nucleolin
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Fig. 1 a Crude-cell extract ELISA of immobilized HcpC (black
triangles), HcpA (black spheres), and BSA (open spheres) with crude
extract of Hek293 cells expressing flag-tagged Nek9. Error bars
represent standard deviations of individual measurements (three
measurements for HcpA and HcpC, two measurements for BSA). The
HcpC/Nek9 interaction data excluding the two measurements at
highest protein concentrations were fitted by a hyperbolic function
(R = 0.9990). b Competition ELISA using extracts of Nek9
expressing Hek293 cells. The absorption at 450 nm is plotted over
the concentration of soluble HcpC using a constant amount of cell
extract (0.05 mg/ml total protein concentration). The HcpC/cell
extract mixtures were incubated in wells with 0.15 lg/well immobi-
lized HcpC (1st read). After 10 min, the mixture was transferred to a
second well and incubated for the same time (2nd read). The
background was estimated by incubating the mixture in wells where
BSA was immobilized instead of HcpC (BSA). Error bars represent
standard deviations for three and two measurements for HcpC- and
BSA coated wells, respectively. c Scatchard analysis of crude-cell
extract competition ELISA. Data were fitted to a linear equation
(R = 0.9920) revealing a dissociation constant of Kd equals
(3.4 ± 0.2) lM
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would be in the proper position to recognize secreted or
membrane-associated HcpC. Surface-exposed nucleolin
serves as a receptor for other H. pylori proteins, such as the
TNF-alpha inducing protein and this interaction has been
implicated in the carcinogenesis of H. pylori [53, 54].
Two very promising hits are Hsc71 and Hsp90, since
both proteins are associated with various processes that
lead to the uptake of bacteria or the signaling that follows
bacterial infection (reviewed in [42]). Among other
functions human Hsc71 serves as a receptor for the uptake
of Listeria monocytogenes and Brucella abortus into tro-
phoblast giant cells. This process is mediated by the
binding of bacterial TPR proteins to the C-terminal EEVD
motif from Hsc71 [52]. HcpC can be regarded as a bacte-
rial TPR protein, because it was shown that the crystal
structures of HcpC and heat shock organizing protein
(Hop), which also belongs to the family of TPR proteins,
are very similar [26]. Furthermore, the conformations and
receptor/peptide interactions are almost identical in HcpC,
which recognizes its own C-terminus, and Hop, which
binds to the C-terminus of Hsp70 and thereby serves as an
adaptor protein that links Hsp70 to Hsp90 (reviewed in
[37]). Hsc71 and Hsp70 share 86% sequence identity and
Hsc71 interacts with Hop in as similar manner like Hsp70
[7]. From a pure structural point of view HcpC could serve
as a bacterial adaptor that links Hsc71 and Hsp90 in a
similar manner like Hop.
Furthermore, the co-chaperones Hsc71 and Hsp70 reg-
ulate the immune response of antigen presenting cells by
modulating the transient aggregation of proteins [21].
Interfering with this process is an efficient strategy for
pathogens such as L. pneumophila to readjust the immune
response of the host, because the aggregation of proteins
ultimately guides the maturation of dendritic cells [18, 23].
Since recombinant HcpA fosters the maturation of Thp1
cells from a monocytic toward a macrophage-like pheno-
type [9] the analysis of the interactions between HcpA,
HcpC, Hsp70, Hsc71, and Hsp90 merits further
investigation.
In this report, we concentrated on the interaction
between HcpC and Nek9, because Nek9 was one of the
most significant hits in the pull-down analysis. The
hypothesis that HcpC and Nek9 could interact was further
supported by the identification of proteins with fused
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Fig. 2 a Western-blot analysis of Hek293 cell extract expressing
Nek9 using an anti-flag mouse antibody (right side) and silver stained
gel of affinity purified Nek9 (left side). The analysis revealed one
major contamination that co-eluted with Nek9. This contamination
was shown to be Hsc71 by in-gel digestion with trypsin followed by
LC–MS/MS analysis and the assignment of eight unique peptides.
b Competition ELISA between flag-tagged Nek9 and HcpC at
different concentrations. Nek9 bound to immobilized HcpC was
quantified using an anti-flag mouse antibody. Fractional saturation
was plotted over the concentration of soluble HcpC. Data were fitted
as a single hyperbolic function (R = 0.9269) as described in
‘‘Methods’’ section and reveals a Kd of (0.5 ± 0.2) lM. The inset
shows the Scatchard analysis of the data. c Surface plasmon
resonance sensograms for the interaction between HcpC and Nek9.
Nek9 was covalently bound to the biosensor surface. Each HcpC
concentration (90, 270, 810, 2430, and 7290 nM) was injected twice.
The inset shows the sensograms for the interaction between HcpA and
Nek9. Each HcpA concentration (402, 804, 1608, 3216, and
6432 nM) was injected twice. Fitting of double referenced data to a
steady-state affinity model gives a Kd of 165 mM for the HcpA/Nek9
interaction
b
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protein kinase and SLR domains. The Rosetta stone model
predicts that domains that participate in a protein complex
can reside either on a single polypeptide chain or on sep-
arate chains in different species [27]. The crude-cell extract
ELISA confirms the initial hypothesis and reveals that the
interaction between HcpC and Nek9 is very specific,
because immobilized HcpA was not recognized by Nek9,
although HcpA and HcpC share 56% sequence identity
(Fig. 1a). This result is consistent with the SPR analysis
where also no interaction between HcpA and Nek9 could
be observed (inset in Fig. 2c).
To obtain an estimate for the binding affinity, the
interaction between purified Nek9 and HcpC was investi-
gated using three different experimental set-ups. All
methods consistently yielded dissociation constants in the
lower micromolar range between 0.5 and 28 lM. The
broad spread could be a consequence of different experi-
mental set-ups and methods to process the data. In the
competition ELISA experiments, Kd values were deter-
mined by using immobilized HcpC and soluble Nek9,
whereas for the SPR analysis immobilized Nek9 and sol-
uble HcpC were used. To show that HcpC directly interacts
with Nek9, experiments with purified proteins were per-
formed. However, over-expressed Nek9 was always con-
taminated with Hsc71 and all attempts to remove this
contamination were so far unsuccessful. Interestingly,
already the pull-down experiments suggested that Hsc71
could interact with HcpC. Therefore, we cannot discern if
HcpC binds either directly to Nek9 or to a Nek9/Hsc71
complex.
Nek9, which is also called Nercc1, belongs to the family
of NimA-like protein kinases that are characterized by a
well conserved N-terminal protein kinase domain and dif-
ferent C-terminal domains (reviewed in [36]). In Nek9,
seven RCC1 repeats occupy the position of the C-terminal
domain. Nek9 plays an important role in microtubule
organization [16, 45] and modulates the activities of further
NimA-like protein kinases, such as Nek6 and Nek7 [1].
Studies using the Xenophus homologue showed that Nek9
is associated with the gamma-tubulin ring complex [44].
The biological significance of the HcpC/Nek9 interac-
tion is currently unclear and the implications of Nek9
during pathogen infections are just emerging. A recent
proteomics study revealed that upon infection with L.
monocytogenis the phosphorylation states of various pro-
tein kinases are modified. Residue Thr333 of Nek9
becomes phosphorylated after treatment with internalin B,
an important stimulant for the uptake of L. monocytogenis
into host cells [43]. This site is located in close proximity
to an established nuclear localization signal of Nek9. In a
second study, it was shown that the sub-cellular distribu-
tion of Nek9 was modified in response to binding of the
human adenovirus E1A protein to Nek9. It was suggested
that E1A—one of the first proteins that are transcribed after
adenoviral infection—alters the function of Nek9 in the
nucleus [39]. These results show that Nek9 is indeed tar-
geted by various factors upon the invasion of bacteria or
viruses.
The interaction between TPR proteins, which are
structurally similar to SLR proteins like HcpC, and protein
kinases are well established. One of the best studied
examples is the interaction between P58IPK and RNA-
activated protein kinase (PKR). P58IPK consists of 9 TPRs
and a C-terminal DnaJ-like domain and participates in the
unfolded protein response during ER-stress conditions. The
PKR binding site was mapped to TPR No. 6 of P58IPK,
whereas the binding site for Hsp40 is located in the DnaJ-
like domain (reviewed in [28]).
Besides the implication of Nek9 in H. pylori infection,
the present study raises a few additional questions, like for
example how HcpC and Nek9 get in touch. HcpC is an
extremely stable molecule with a melting temperature of
65C, which is either secreted into the culture supernatant
or absorbed to the outer membrane of H. pylori cells [2, 26,
46]. The HcpC homologues LpnE, EnhC, and LidL are
known to confer phagocytotic uptake of L. pneumophila
into host cells [6, 24, 34] and the H. pylori homologue
HcpA reveals a similar activity (P.R.E.M. unpublished
observation). Therefore, HcpC would be in the proper
position to enter the phagosome but these experiments do
not answer the question how HcpC penetrates from the
phagosome into the cytoplasm. Perhaps, its extraordinary
stability enables HcpC to survive the final stages of the
phagolysosome. Further studies are clearly necessary to
resolve these questions.
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